Publication date: Mar 02, 2020
In a new study, researchers found that a commonly used anti-psychotic medication was linked to adverse changes in brain structure.
But the adverse changes in brain structure found in this study are an important consideration for prescribing for psychiatric conditions where alternatives are possible.
The team found evidence that the use of olanzapine was linked to adverse changes in brain structure, namely a thinning of the cortex.
But participants who experienced a relapse of psychotic symptoms also had potentially adverse changes in brain structure, emphasizing the essential role antipsychotics play in treating disorders where psychosis is present.